tiprankstipranks
Trending News
More News >
Regencell Bioscience Holdings Ltd. (RGC)
:RGC
US Market

Regencell Bioscience (RGC) Financial Statements

Compare
535 Followers

Regencell Bioscience Financial Overview

Regencell Bioscience's market cap is currently $8.31B. The company's EPS TTM is $-0.33; its P/E ratio is -2,627.78; Regencell Bioscience is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in USD

Regencell Bioscience Earnings and Revenue History

Regencell Bioscience Debt to Assets

Regencell Bioscience Cash Flow

Regencell Bioscience Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.